Correlation Between Clal Biotechnology and Kamada

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Kamada at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Kamada into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Kamada, you can compare the effects of market volatilities on Clal Biotechnology and Kamada and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Kamada. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Kamada.

Diversification Opportunities for Clal Biotechnology and Kamada

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Clal and Kamada is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Kamada in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kamada and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Kamada. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kamada has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Kamada go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Kamada

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to generate 1.81 times more return on investment than Kamada. However, Clal Biotechnology is 1.81 times more volatile than Kamada. It trades about 0.1 of its potential returns per unit of risk. Kamada is currently generating about -0.13 per unit of risk. If you would invest  4,450  in Clal Biotechnology Industries on January 26, 2024 and sell it today you would earn a total of  190.00  from holding Clal Biotechnology Industries or generate 4.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  Kamada

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Clal Biotechnology Industries are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak forward indicators, Clal Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.
Kamada 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kamada has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Kamada is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Clal Biotechnology and Kamada Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and Kamada

The main advantage of trading using opposite Clal Biotechnology and Kamada positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Kamada can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kamada will offset losses from the drop in Kamada's long position.
The idea behind Clal Biotechnology Industries and Kamada pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Share Portfolio
Track or share privately all of your investments from the convenience of any device